[HTML][HTML] Recent developments on therapeutic and diagnostic approaches for COVID-19
J Majumder, T Minko - The AAPS journal, 2021 - Springer
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
Coronavirus disease 2019 (COVID-19): current status and future perspectives
H Li, SM Liu, XH Yu, SL Tang, CK Tang - International journal of …, 2020 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei
Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is …
Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is …
[HTML][HTML] Potently neutralizing and protective human antibodies against SARS-CoV-2
The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
Potential interventions for novel coronavirus in China: A systematic review
L Zhang, Y Liu - Journal of medical virology, 2020 - Wiley Online Library
An outbreak of a novel coronavirus (COVID‐19 or 2019‐CoV) infection has posed significant
threats to international health and the economy. In the absence of treatment for this virus …
threats to international health and the economy. In the absence of treatment for this virus …
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
X Tian, C Li, A Huang, S Xia, S Lu, Z Shi… - Emerging microbes & …, 2020 - Taylor & Francis
The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900
laboratory-confirmed human infections, including 259 deaths, posing a serious threat to …
laboratory-confirmed human infections, including 259 deaths, posing a serious threat to …
[PDF][PDF] Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
B Shanmugaraj, K Siriwattananon… - Asian Pacific journal …, 2020 - apjai-journal.org
Last decade witnessed the outbreak of many life-threatening human pathogens including
Nipah, Ebola, Chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS …
Nipah, Ebola, Chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS …
[HTML][HTML] Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Antibodies are a principal determinant of immunity for most RNA viruses and have promise
to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 …
to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 …
[HTML][HTML] SARS-CoV-2 is transmitted via contact and via the air between ferrets
Abstract SARS-CoV-2, a coronavirus that emerged in late 2019, has spread rapidly
worldwide, and information about the modes of transmission of SARS-CoV-2 among …
worldwide, and information about the modes of transmission of SARS-CoV-2 among …
[HTML][HTML] A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Antibody-dependent enhancement (ADE) of disease is a general concern for the
development of vaccines and antibody therapies because the mechanisms that underlie …
development of vaccines and antibody therapies because the mechanisms that underlie …